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The Gilles de la Tourette syndrome (GTS) is a neurobehavioural disorder characterized by multiple motor and 
vocal tics. Accessory symptoms include coprophenomena, echophenomena and obsessive-compulsive behaviours. 
There is a significant genetic ontribution to their aetiology. Simple tics may be mistaken for myoclonic epilepsy 
and complex tics for complex partial seizures. Like epilepsy, GTS is a brain disorder that leads to general 
disturbances in behaviour not just the cardinal symptoms (i.e. tics or seizures). 
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INTRODUCTION 
Although George Brutus Gilles de la Tourette ~ 
was the first to describe a series of cases of a 
syndrome of tics, coprolalia and echolalia, there 
were several previous reports of the syndrome. 
Friend 2 described a family of 'barking' girls. 
Itard 3 described the symptoms of GTS in the 
Marquise de Dampierre with onset at the age of 
seven. Her symptoms included tics of the arms 
and face a.s well as obscene vocalizations. She was 
forced to live as a recluse. Recent authors have 
speculated that GTS may have affected Samuel 
Johnson 4 who exhibited motor tics in multiple 
locations as well as counting rituals and 'forced 
touching'. He was also observed having to 
approach doors with a certain number of steps 
and enter them with a particular foot. If he erred 
in his ritual he would have to begin again. 
At the end of the 19th Century, a number of 
'culture bound' syndromes were described in- 
cluding 'latah' and 'Myriachit' whose central 
feature was hyperekplexia (exaggerated startle 
response) but included echolalia and coprolalia. 
The 'jumping Frenchmen' of Maine 5 exhibited 
hyperekplexia, coprolalia nd echolalia and had a 
marked familial component. Initially, Gilles de la 
Tourette classified tics alongside these startle 
reactions, which were induced rather than spon- 
taneous. This led to an initial overemphasis on 
echophenomena as a central feature of the 
syndrome. 
More recently described ticquers include 'Witty 
Ticcy Ray '6 whose tics and coprolalia llowed him 
to be an effervescent jazz drummer and racon- 
teur. On treatment with haloperidol, his tics 
disappeared along with his effervescence and 
ability to improvise. Kurt Cobain, lead singer of 
cult group Nirvana was said to suffer from GTS 
and his song 'Tourette' details the misery some 
can experience from the syndrome. He killed 
himself in 1994. 
Gilles de ia Tourette himself was shot in the 
neck by a deluded woman at the Salpetriere in 
1893 and finally died in Switzerland suffering 
from general paralysis of the insane (GPI). 
EPIDEMIOLOGY OF GTS 
The exact prevalence of GTS is difficult to 
ascertain. It does not have a discrete phenotype 
and individuals may either be reluctant to present 
or do not have symptoms of sufficient severity. A 
reasonable lifetime prevalence figure is 1.5/10007 . 
It is found in all major areas of the world 
including Australia 8, Saudi Arabia 9, Ceylon ~°, 
China and Japan I~. 
GTS is more common in males than females ~2. 
It is more common in lower social classes ~3 and 
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sufferers often do not achieve the social status of 
their parents, t4 
CLINICAL SYMPTOMS AND COURSE OF 
ILLNESS 
GTS is defined as multiple motor and one or 
more vocal tics with onset before the age of 21 
years and not associated with intoxication or 
other known CNS disease ~5. 
A tic is a rapid, non-rhythmical movement 
which may be simple (eye blink, nose flare, mouth 
to side) or complex (jumping, turning round, 
kissing oneself, copulatory movements, melling, 
adjusting clothing, animal noises). Tics are 
usually preceded by a premonitory urge; a 
tension, squeezing or tightness often located in 
the area about to tic. This urge is usually 
temporarily relieved by ticcing. Tics can occur in 
any voluntary muscle group in the body but are 
rarely simultaneously bilateral in the extremities 
(they do occur in the midline). They can usually 
be replicated at will and are suppressible for 
varying amounts of time. They tend to occur in 
bouts. People with GTS may well be able to 
suppress tics for the duration of an out-patient 
appointment but may be heard or seen ticcing 
when leaving the clinic. Tics in people with GTS 
tend to wax and wane. The tics vary in frequency, 
severity and location with time. 
Mean age of onset for GTS symptoms is 7 
years. Tics usually start in the facial area with eye 
tics being the most frequent initial tic. Vocal tics 
start at a mean age of 11 years. Copro- and 
echophenomena and obsessive-compulsive (OC) 
behaviours often start in mid-puberty (mean age 
of onset 14-15 years). The syndrome waxes and 
wanes but tends to be worst in adolescence and 
early adulthood and to mellow in middle age 
although complete remission is rare, occurring in 
only about 8% of cases t~'. Symptoms tend to be 
exacerbated by anticipatory anxiety and febrile 
illness. Occasionally, complete remission can be 
followed by reappearance of symptoms at a later 
date. A poor prognosis is indicated by coprolalia 
and lower limb or body tics ~7. 
Symptoms associated with GTS include cop- 
rolalia (swearing as a tic) and copropraxia 
(obscene gestures as a tic). These phenomena are 
present in around 30% of clinic populations with 
GTS and around 5% of a community population 
with GTS t~. Swearing as a tic is non-contextual 
and patients with coprophenomena often attempt 
to suppress it or convert it into other, more 
acceptable, words or gestures. Coprolalia occurs 
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in many cultures. Lieh Mak's study of Hong Kong 
Chinese with GTS t'~ detailed coprolalia including 
the words 'flu ma' (motherfucker) and 'tiu so' 
(aunt fucker). Nomura and Segawa j~ detailed 
coprolalia in a Japanese group with GTS and 
words included 'kusobaba' (shit grandma) and 
"chikusho' (son of a bitch). Echolalia and 
echopraxia (repeating the words and gestures of 
others) are less common clinical signs as are 
palilalia and palipraxia (perseverating on the final 
action or word in a series). 
Obsessive-compulsive phenomena, however, 
are very common in GTS. In one typical study TM 
around 40% of clinic attenders with GTS had 
obsessive or compulsive behaviours. Obsessions 
and compulsions share some of the same psycho- 
pathology as tics (a premonitory urge and relief 
following the tic). OC symptoms in GTS are most 
commonly related to symmetry, counting and 
touching rituals. This includes 'forced touching' 
of certain materials or of dangerous objects (such 
a hot surface), 'evening up" rituals, arithromania 
(compulsive counting of objects) 2". Germ phobias 
or cleaning rituals are less common in GTS. 
Interestingly, the natural history of GTS is not 
dissimilar to that of OC disorder with waxing and 
waning of symptoms, a worsening in early 
adulthood and an improvement in late adulthood. 
The reported mean age of onset of OCD is later 
that that of GTS but this may be that tics are 
more noticeable to others than obsessions. 
Although there is a considerable overlap between 
GTS and OCD/OC behaviours, there are a large 
group of patients with GTS who never have OCD 
and a larger group of patients with OCD who do 
not have GTS 2~. 
DIFFERENTIAL DIAGNOSIS OF TOURETTE 
SYNDROME 
Tics have to be distingushed from other disorders 
of movement including myoclonus or chorea (see 
Table 1). Tics can be distinguished from myoc- 
lonus in the following ways. Myoclonus may be 
rhythmic or bilateral (although not always). It 
does not have a premonitory urge or subjective 
relief following the action. It is not predictable, 
reproducible or suppressible and does not usually 
present as complex movements. 
Choreiform movements often resemble tics 
but, like myoclonus, do not have an associated 
premonitory urge or relief following the action 
and do not occur in bouts. Unlike tics, chorea 
tends to be aggravated by voluntary movement 
and is more difficult to suppress. 
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Table 1: Clinical features of GTS, myoclonus and chorea 
GTS Myoclonus Chorea 
Premonitory urge + 
Relief after event + 
Rhythmic 
Suppressible + 
Complex movement + / - 
Sudden + 
Occur in bouts + 
Vary in location + 
Bilateral outside midline 
Coprophenomena + 
Echophenomena + 
OC phenomena + 
Vocalizations + 
Palilalia/praxia + 
Worsened by anxiety + 
+ - 
+ - 
+ 
+ - -  
+ - -  
+ 
m 
+/-  
+ 
+ 
+/-  
+/ -  
+/ -  
+/ -  
+ 
Myoclonus, tics and dystonia can present 
simultaneously in individuals. Feinberg '2 re- 
ported four patients who presented at the New 
York GTS clinic with paroxysmal myoclonic 
dystonia and vocal tics who had no EEG 
abnormalities and who were not responsive to 
standard tic medications. 
It is worth noting that all these movement 
disorders and many others (including tremor and 
dystonia) can be exacerbated by anxiety or stress 
making this a poor way of discriminating between 
syndromes. 
There are also idiopathic tic disorders that do 
not meet the criteria for GTS. These include 
chronic motor/vocal tics (thought by some to be 
part of the inherited GTS spectrum) which is a 
syndrome of long:-standing motor or vocal tics, 
but not both, and transient tic disorder, which is a 
short-lived motor or vocal tic disorder (less than 
12 months). Tics can also appear as part of a 
recognized neurological syndrome such as 
Huntington's or Wilson's diseases, encephalitis 
lehargica (which is now rare but presented with a 
number of neuropsychiatric symptoms including 
coprolalia, echolalia and OC behaviours), cere- 
brovascular disease, cerebral trauma, Alzheimer 
type dementia nd metabolic encephalopathies 23. 
Sydenham's chorea can present in childhood with 
tics and OC behaviours and some authors now 
believe that many cases of GTS are related to 
streptococcal infections 24. 
Lesch-Nyhan syndrome, a hereditary disorder 
of purine metabolism is usually diagnosed in the 
second year of life. Symptoms include tics, 
coprolalia, self-mutilation and mental 
retardation. 
Tics have also been reported following the 
administration of neuroleptic medications in the 
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short-term 25and long-term 26. They can also be 
produced or exacerbated by stimultant drugs such 
as amphetamines or 'Ecstasy'. Anticonvulsants 
(e.g. carbamazepine) have rarely been reported 
to produce tics 27. Other syndromes in which 
tic-like movement disorders are prominent in- 
clude manganese poisoning, acanthocytosis and 
hypoparathyroidism 2~ but these can be excluded 
with a good history and relevant laboratory 
investigations. 
GTS has to be differentiated from the hyper- 
ekplexias (exaggerated startle response) some of 
which present in childhood and can be inherited. 
These occur only in response to external stimuli 
and have a stereotyped nature. Klazomania is a 
term introduced by Benedek 2'~ to describe shout- 
ing (and sometimes coprolalia) in patients with 
encephalitis. The condition is ~lso associated with 
oculogyric risis, echolalia and jerky movements. 
GTS may be confused with epileptic syndromes 
in two main ways. Myoclonic epilepsies may 
resemble simple motor and, rarely, vocal tics and 
complex motor or vocal tics may be mistaken for 
partial seizures. Juvenile myoclonic epilepsy 
(JME) can present with simple myoclonus and its 
mean age of onset is similar to that of GTS but 
the movements, though sudden are neither 
predictable nor suppressible. They tend to be 
worse after waking and can occur bilaterally in 
the periphery, which would be very unusual for 
GTS. JME has not been associated with cop- 
rolalia, echolalia or OC symptoms. 
Complex vocal or motor tics (such as copula- 
tory movements, niffing objects) and compulsive 
rituals (such as adjusting clothing or checking 
rituals) may be difficult to distinguish from partial 
seizures or post-ictal automatisms except that, 
when these behaviours occur as part of a seizure 
or post-ictaily, there will usually be evidence of 
impaired consciousness and no memory for 
events after the recovery. At the time of the 
seizure, the behaviour may be perceived as a 
compulsion. Partial seizures may be experienced 
as a 'rising' feeling in the chest or abdomen or as 
nausea or retching. These phenomena have also 
been described in children with GTS. Coprolalia 
or copropraxia (including spitting) may occur as 
part of a complex partial seizure or during a 
post-ictal automatism. This may be in the form of 
single words (like GTS) or complete sentences 
(unlike GTS). Occasionally, coprophenomena 
occur in the setting of ictal rage. Usually, no 
attempt is made to disguise the swearing. 
Using the symptom of tongue biting in order to 
distinguish seizures from GTS can be misleading; 
self-injury is common in GTS (up to 40% 30 and 
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may include compulsive tongue biting. The 
tongue biting related to seizures is usually on the 
sides of the tongue rather than across it. 
The electroencephalogram (EEG) is com- 
monly used in the diagnosis and classification of 
epilepsies. In GTS the EEG is rarely useful 
except sometimes as a means of excluding some 
other neurological disorders presenting with tics, 
such as epilepsy. Although non-specific EEG 
abnormalities have been described in GTS, there 
is no recordable cortical event which correlates 
temporally with tics. Neufeld et a131 looked 
prospectively atthe EEG's of 48 people with GTS 
and matched controls without known cerebral 
disorder. They detected, blindly, non-specific 
abnormalities in 6% of GTS subjects and 7% of 
controls. The consensus of opinion is that the 
EEG is not generally useful in the study of the 
aetiology, management or diagnosis of GTS. 
In terms of treatment, it is important to 
distinguish tics from epileptic syndromes as many 
treatments for tics (such as neuroleptics) will lead 
to a lowering of seizure threshold and worsening 
of symptoms in those with seizures. 
GTS AND BRAIN BIOLOGY 
Research into the aetiology of GTS has grown 
massively in the last ten years. The main areas of 
biological research are genetics, imaging, neur- 
ochemistry and neuropathology. 
Gilles de la Tourette himself was the first to 
suggest that GTS was a familial condition. 
Epigenetic studies indicate that concordance in
monozygotic twins is around 55% (increasing to 
77% if chronic motor tics are included). Dizygotic 
concordance is around 10% 32"33. There is a single 
study of reared apart triplets, all of whom had the 
diagnosis of GTS, enough evidence in itself to 
show a significant genetic ontribution to GTS 34. 
Extensive segregation analyses performed on 
families, pedigrees and sib-pairs have indicated 
that the most likely mode of inheritance is 
autosomal dominant with high penetrance ( spe- 
cially in males), the phenotype being GTS and 
OC behaviours 35-37. However, the fact that no 
single GTS gene has been found 3s has led to this 
model being questioned. Currently 95% of the 
genome has been excluded in certain pedigrees 
using specific models of inheritance. Some 
authors have recently suggested other modes of 
inheritance and wider phenotypes including sleep 
disorders, paraphilias, attention deficit disorder, 
gambling and alcoholism 3'~ and bilineality in GTS 
pedigrees has been described4~L Currently, genes 
for a number of receptor subtypes are being 
cloned and tested in GTS pedigrees 4t. There has 
been no positive linkage so far. 
Brain imaging is another tool used to establish 
aetiology in GTS. Computed tomography (CT) 
studies of patients with GTS have shown an 
increase in non-specific findings (porencephalic 
and arachnoid cysts, colpocephaly and calcifica- 
tion in the third ventricle and periaqueductal 
grey) with a rate of around 13% t4. Studies 
comparing the ventriculo-brain ratio (VBR) of 
patients with GTS and healthy controls have 
shown no differences. Quantitative magnetic 
resonance imaging (MRI) studies have indicated 
volumetric differences between GTS subjects and 
controls, especially in the basal ganglia 42"43. 
Functional imaging using single photon emission 
tomography (SPET) and positron emission tom- 
ography (PET) tends to show reduced perfusion 
and metabolism in the basal ganglia of GTS 
subjects "~'4-~ and elevated frontal blood flow 4". 
Although one SPET study looking at function of 
receptor subtypes indicated that binding rate of 
dopamine-2 receptors in the basal ganglia was 
slower in GTS subjects than controls 47, all other 
functional imaging studies have indicated an 
intact dopaminerg!c system in nigrostriatal and 
mesolimbic systems. 
Neurochemical work has focused on the main 
neurotransmitter systems including dopamine, 
serotonin, acetylcholine and noradrenaline. 
These substances and their metabolites have been 
measured under different conditions and in 
different body substances. Drugs which block 
dopamine receptors have great efficacy in reduc- 
ing tics and drugs which encourage dopamine 
release or prevent reuptake (e.g. amphetamines) 
appear to make tics worse. There are three 
studies showing a decrease of homovanillic acid 
(a direct metabolite of dopamine) in the cere- 
brospinal fluid of subjects with GTS 48-~° and one 
study showing an increase of this following 
treatment with haloperidol ~. However, many 
aspects of dopamine function have been studied 
using radiolabelled receptor iigands with no 
robust abnormalities detected s" . It may be that, 
despite changes in Cerebro Spinal Fluid (CSF) 
chemistry, the action of dopamine blocking drugs 
is to induce a mild dystonia nd it is this which 
leads to a reduction in tics. Serotonin dysfunction 
is also a possibility in people with GTS. Many 
conditions associated with GTS (e.g. obsessive- 
compulsive disorder, sleep disturbance and prob- 
lems with impulse control) have also been 
associated with serotonin dysfunction. Two 
plasma studies have shown a decrease in tryp- 
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tophan (a serotonin precursor) in GTS 3'~ and a 
small study shows abnormalities in the kynure- 
nine pathway, the main pathway of tryptophan 
metabolism 53. This pathway contains several 
known neuroactive chemicals including quinolinic 
acid and kynurenic acid. No drugs acting specifi- 
cally on the serotonin system have been shown to 
improve tics although most specific serotonin 
reuptake inhibitors have a beneficial effect on the 
obsessive symptoms associated with GTS. Other 
neurotransmitter systems have been studied 
including noradrenaline and acetyl choline but no 
significant abnormalities have been discovered. 
There are very few neuropathological studies 
of GTS as this is not a fatal condition. Haber 54 
found a marked decrease of dynorphin-like 
substances in the basal ganglia of six GTS brains 
when compared with controls. In lesioned ani- 
mals, areas involved in the production of rapid 
movements and vocalizations include the amyg- 
dala, hypothalamus, ubstantia nigra and rostral 
periaqueductal grey matter. Stimulation of some 
of these areas will lead to production of 
vocalizations with associated affective changes ~5. 
Stimulation of the amygdala in humans during 
awake craniotomy can lead to vocalizations and 
an associated violent affect ~'. However, vocaliza- 
tions in GTS are not usually associated with an 
aggressive or angry affect. 
BEHAVlOURAL PROBLEMS ASSOCIATED 
WITH GTS 
As with epilepsy, children and adults with GTS 
may often have behavioural disorders and learn- 
ing difficulties, partly as a result of generalized 
brain pathology and partly as a result of their own 
or others' reactions to their illness. They can 
often be thought of as attention seeking and 
manipulative (and sometimes they are) and their 
tics and habits can be disruptive, especially in the 
classroom. Overtly sexualized behaviour, which 
includes coprolalia and copropraxia and other 
sexually inappropriate activity can occur and be a 
problem. This may lead teachers and others to 
suspect sexual abuse. However, there are no 
studies suggesting a link between sexual abuse 
and GTS. Sexualized behaviours may simply be 
another aspect of the syndrome. 
Children with GTS often have specific prob- 
lems with inattention, impulsivity and 
overactivity 5v. About 50% of children with GTS 
have attention deficit disorder (ADD). This 
compares with an estimated prevalence in US 
schoolchildren of between 2 and 14%. ADD can 
be effectively managed with drugs and specific 
educational strategies. In general, the IQ spectrum 
of people with GTS is within the normal range. 
Initial studies indicate that impaired concentra- 
tion and attention are present in many:'. Execu- 
tive function is impared in children with GTS 
who also have ADD but not in GTS alone 5'~. 
Dykens et a l  ~" showed that children with GTS 
showed a relative strength in reading and a 
relative delay in arithmetic ompared with chil- 
dren with ADD and controls. 
MANAGEMENT IN GTS 
The decision to treat and which form of treatment 
to use in GTS is dependant on the degree to 
which symptoms are interfering with function "~. 
Treatment may include pharmacological, psycho- 
logical and environmental interventions. 
For nearly three decades, chemotherapy has 
been the mainstay of treatment for GTS. The 
main medications have been haloperidol, pimo- 
zide, sulpiride and clonidine. Haloperidol is 
effective in small doses and the majority of 
sufferers obtain improvement on it initially "2. 
Longer term studies are less encouraging with 
onlv 20-30% continuing to use and benefit from 
haloperidol. Haloperidol has been implicated in 
the causation of tardive dyskinesia in a patient 
with GTS in one case report "3 and studies on its 
effect on psychometric function have not been 
performed in GTS. 
Pimozide is chemically distinct from haloperi- 
dol and phenothiazines but it is still a potent 
dopamine antagonist. Clinical studies show it to 
be equivalent to, and less sedating than. 
haloperidol ~''5. The side-effects are similar to 
those of haloperiodol but also include potentially 
dangerous EC changes requiring ECG monitor- 
ing. The evidence for the efficacy of clonidine, an 
a-2 agonist is less clear cut with around 4(J% of 
patients benefiting initially ''''7. Clonidine appears 
to have a slower onset of action and its major 
adverse ffects include sedation and hypotension. 
It is the first line treatment for concurrent TS and 
ADD t". Sulpiride mainly antagonizes dopamine-2 
receptors. It is associated with a much lower risk 
of tardive dyskinesia so far and has been used in 
the treatment of GTS. Robertson"" reported tic 
reduction in the majority of a group of 114 
patients on the drug. So far there have been no 
placebo-control studies of its efficacy. Resp- 
iridone, a novel antipsychotic which blocks 
nigrostriatal dopamine receptors as well as 5HT2 
receptors has been reported to reduce tics 
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exceptionally in about 50% of patients and very 
little in the remainder. No placebo control studies 
of it's efficacy have been performed. 
Other drugs used in GTS include penfluridol ~2, 
fluphenazine 6', clonazepam v°, physostigmine 7~,
and tetrabenazine 72. These all require further 
evaluation. 
Drugs which inhibit reuptake of serotonin are 
very useful in the management of obsessions and 
compulsions in GTS. Fluoxetine and sertraline 
have proven effective in the treatment of OC 
symptoms and can often be used in combination 
with neuroleptics or clonidine. Side-effects in- 
clude nausea, sleep disturbance and sexual 
dysfunction 73. 
Drugs treatment in GTS are imperfect and 
carry with them the risk of damaging side-effects. 
Therefore it is imperative to search for more 
effective, less toxic drugs in this condition. 
Non-pharmacological treatments have been 
used in GTS and are empirically useful. These 
include monitoring baseline and progression of 
symptoms, reassurance during difficult periods 
and psychotherapy for adjustment disorders or 
personality difficulties either associated with or 
independent from the GTS itself. Family therapy 
or support groups such as the GTS Association 
may also be useful for sufferers and their families. 
School interventions may help those with GTS 
especially if this is associated with specific 
learning difficulty or ADD. Different behavioural 
therapies have been evaluated in the treatment of
GTS including habit reversal, massed practice 
and relaxation v~-w. In general, habit reversal 
(immediate control of the tic followed by exercise 
of the opposing muscle groups) appears the most 
effective of the behavioural treatments. However, 
this technique is only appropriate for certain 
kinds of tics and the majority of studies were on 
less than five subjects with no control groups. 
Polites vv caused complete cessation of tics during 
hypnosis for a 15-year-old boy but the tics 
returned as soon as the patient resumed his 
normal conscious tate. 
CHALLENGES IN THE FUTURE 
The biggest challenge is to establish the genetic 
aetiology of GTS. This is at a crucial point as no 
single gene has been isolated using an autosomal 
dominant mode of inheritance. It may be that 
GTS represents a heterogeneous condition with 
overlap into a number of related conditions, 
especially ADD and OCD. Evaluation of the 
biological aetiology of these conditions would 
help us to understand GTS further. Elucidation of 
brain function (especially neurochemistry and 
imaging) would give clues to genetics and help in 
the development of less toxic treatment 
strategies. 
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